Model-based evaluation of the cost effectiveness of 3 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

Model-based evaluation of the cost effectiveness of 3 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

Background: Our aim was to evaluate the cost effectiveness of 3 months’ adjuvant chemotherapy versus 6 months in high-risk (T4 stage + microsatellite stable) stage II colon cancer (CC) patients. Methods: Using the validated PATTERN Markov cohort model, which simulates the disease progression of stag...

Full description

Bibliographic Details
Main Authors: Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé
Format: Article
Language:English
Published: SAGE Publishing 2020-09-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284820954114

Internet

https://doi.org/10.1177/1756284820954114

Similar Items